ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

World's First Medically Approved Menopause Health & Wellbeing Companion Launches

Screenshot from balance+

balance+ is the new, holistic service to help you take charge of your menopause journey

LONDON, ENGLAND, March 21, 2022 /EINPresswire.com/ -- In an effort to help those experiencing perimenopause and menopause look holistically at improving their future health, menopause support app balance has introduced balance+, as an extended area of the app bringing a wealth of exclusive content to the platform.

Handpicked by leading menopause specialist Dr Louise Newson, balance+ gives you unparalleled access to the best specialists and clinicians in the field, all coming together to help you optimise your mental health, nutrition, sleep, physical health, sexual health as well as your skin and hair.

Designed as the next stage, or in addition to getting treatment, balance+ is a step up for users. Brought to you by the ORCHA accredited free app balance, already downloaded by hundreds of thousands of women in over 150 countries, the same features included in the original app such as personalised symptom trackers, individualised health report and access to a global community are still available for free. However, balance+ subscribers will also be able to access expert advice through videos, recipes, classes and more. These experts include Dr Rebecca Lewis, GP and menopause specialist, Emma Ellice-Flint, clinical nutritionist, Lucy Holtom, yoga teacher, Dr Claire Macaulay, sex specialist, Dr Sajjad Rajpar, consultant dermatologist and Dr Sally Norton, weight loss specialist and medical doctor. All balance+ experts are uniquely placed combining their discipline with specialised knowledge at the intersection of menopause. balance+ also includes monthly live webinars and Q&As with Dr Louise Newson, inviting questions from the community.

Dr Louise Newson, founder of balance, said “The launch of balance+ comes at a pivotal time to improve health for perimenopausal and menopausal women. We know that everyone experiencing perimenopause and menopause has different needs and that’s why balance+ takes a holistic and personalised approach which really puts the user in control. Working closely with our community to gain valuable insights and feedback has allowed us to make balance+ happen and I thank the community for supporting us with this menopause movement”.

balance+ has a monthly subscription cost of £9.99 a month, inclusive of a complimentary seven-day trial or £89.99 annually. balance believes that evidence-based information that empowers women and helps to facilitate a quicker diagnosis and access to treatment should always be 100% free. Those choosing to subscribe to balance+ for additional features will help support this mission and keep the rest of balance app free, for all.

This model is also open to corporate partners. Organisations such as Irwin Mitchell, Immediate Media, Bruntwood and Serco, the international provider of services to Governments, are already signed up to pilot balance+ to their workforce.

Subscribe to balance+ and feel a difference whilst making a difference. The app is available to download on the App Store and on Google Play.

-ENDS-

Images of the app can be found here.

About balance
Founded by Dr Louise Newson, balance app is the only menopause app certified by ORCHA and recognised as safe, accredited, compliant, and trusted to feature in digital health libraries for the NHS and other national health bodies around the world.
Created with a single mission in mind, to make menopause support inclusive and accessible to all, balance app provides evidence-based and unbiased information to help you become better informed, prepared and empowered during the perimenopause and menopause.

Rachel Sewell
Skating Panda
rachel@skatingpanda.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.